HOUSTON, TX -- (MARKET WIRE) -- May 17, 2007 -- MicroMed Cardiovascular, Inc. (OTCBB: MMCV) developer of the DeBakey VAD® is pleased to announce the first Bridge to Recovery patient in the U.S. The patient was enrolled in MicroMed Cardiovascular, Inc.'s Bridge to Transplant study.
